# Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients

> **NCT02706652** · — · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 8 (actual)

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02706652
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-22
- **Primary completion:** 2019-09-06
- **Final completion:** 2019-09-06
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Closed because the study is no longer needed. The related studies this project supported have closed, so no further work is needed.
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02706652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02706652, "Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT02706652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*